Sessions: 12 - 14 July 2010

Review the Conference Program

Program Update: Session 6: Stem cells and early development
Andreas Eckelt, FCMB, Denmark, is presenting “Fetal cells from maternal blood: A powerful tool for prenatal diagnosis” at the end of Session 6 from 12:10 - 12:25 pm in E104 - 107.

A Welcome Reception will be held on the evening of Monday, 12 July 2010 at the Strandzuid "Party Beach," which is adjacent to the RAI at Europaplein 22. This reception is planned in lieu of an Opening Reception on Sunday, 11 July 2010.

Controversies in Prenatal Diagnosis

Conference sessions will include debates on current controversies in the field, including the following topics:

Is stem cell therapy ready for human fetuses?
FOR: Magnus Westgren (Sweden)
AGAINST: Christine Mummery (Netherlands)
Down syndrome screening: Is ultrasound is better than cell-free nucleic acids in maternal blood?
FOR ULTRASOUND: Beryl Benacerraf (USA)
FOR NUCLEIC ACIDS: Simcha Yagel (Israel)
Is conventional analysis (karyotyping and FISH) necessary in the
post-array CGH era?
FOR: Lisa Shaffer (USA)
AGAINST: Orsetta Zuffardi (Italy)
Does industry sponsorship accelerate or hinder the pace of research?
FOR: Gajus Worthington (USA)
AGAINST: Sigrid Sterckx (Belgium)

Conference Session Speakers

Conference sessions will include talks by leading experts and selected abstract presentations. For abstract presentation titles and speakers, please see the preliminary conference program.

ISPD is proud to announce the participation of the following invited speakers on conference days Monday, Tuesday and Wednesday.

Monday, 12 July 2010

Opening Plenary
- Genomics Medicine: The Future: Lord Patel (UK)
Fetal Therapy: Surgical Approach
- Prenatal treatment for congenital bladder neck obstruction: Is there a role? Mark Kilby (UK)
- New and/or improved aspects of fetal surgery: Francois Luks (USA)
Ethical issues in prenatal diagnosis
- Recent advances in personal genome testing: Cecile Janssens (Netherlands)
- Ethical dilemmas: When will total genome analysis play a role in prenatal diagnoses? Guido de Wert (Netherlands)
Preimplantation genetic diagnosis
- Update on PGD for chromosomal abnormalities:
  Carmen Rubio (Spain)
- PGD for monogenic diseases: Update on technologies, indications and outcomes: Martine De Rycke (Belgium)
Fetal imaging and anomalies
- What is the best fetal imaging technique to diagnose skeletal dysplasias? Deborah Krakow (USA)
- 3D ultrasound in obstetrics: Lessons learned and the way
  forward: Karim Kalache (Germany)

Tuesday, 13 July 2010

Fetal cells and cell-free nucleic acids in maternal circulation
- DNA or RNA: Which is better for noninvasive diagnosis of aneuploidy? Dennis Lo (Hong Kong)
- Non-invasive aneuploidy detection using methylation-sensitive
  amplification of maternal plasma DNA followed by microarray analysis: Stephen Brown (USA)
Stem cells and early development
- Cell (pre)-destiny in the human preimplantation embryo and implications for IVF and PGD: Hilde Van de Velde (Belgium)
- The role of germline and early embryo DNA methylation dynamics in normal fetal development: Jacquetta Trasler (Canada)
Molecular and classical cytogenetics
- CNVs and structural rearrangements in the human genome:
  Charles Lee (USA)
- Array CGH in prenatal diagnosis: Joris Vermeesch (Belgium)
Prenatal screening for fetal anomalies
- Fetus-specific risk estimation in twins: Howard Cuckle (USA)
- What can the First Trimester Scan tell us? Douglas Wilson (Canada)

Wednesday, 14 July 2010

Genome wide analysis in prenatal diagnosis
- Preeclampsia: Kenneth Ward (USA)
- Preterm birth: Craig Penell (Australia)
Fetal therapy: Innovative non-surgical approach
- The genomic approach. Donald Peebles (UK)
- The stem cell approach. Nick Fisk (Australia)

Quick Links

Attendee Information

Schiphol Airport

Amsterdam Forecast

Amsterdam RAI

Public Transit Maps